BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6182701)

  • 21. Combination chemotherapy with cis-dichlorodiammineplatinum(II) in disseminated testicular cancer.
    Einhorn LH
    Cancer Treat Rep; 1979; 63(9-10):1659-62. PubMed ID: 91434
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction.
    Einhorn LH; Williams SD; Mandelbaum I; Donohue JP
    Cancer; 1981 Aug; 48(4):904-8. PubMed ID: 6168361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of nonseminomatous testicular tumor with liver metastases].
    Masuda F; Nakada J; Kondo N; Takahashi T; Mochizuki A; Iizuka N
    Hinyokika Kiyo; 1988 Feb; 34(2):351-5. PubMed ID: 2454020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle].
    Germa Lluch JR; Bastus Piulats R
    Actas Urol Esp; 1987; 11(3):293-8. PubMed ID: 2444075
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of advanced testicular seminoma--chemotherapy and serum marker].
    Nakamura K; Hagiwara M; Aikawa A; Deguchi N; Tazaki H; Takeshita E; Ito S
    Gan No Rinsho; 1983 Dec; 29(15):1779-82. PubMed ID: 6199531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Individualized interval shortening in the chemotherapeutic induction treatment of solid tumors (author's transl)].
    Seeber S; Higi M; Niederle N; Schmidt CG
    Dtsch Med Wochenschr; 1981 Dec; 106(51-52):1741-4. PubMed ID: 6173182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case report of extragonadal germ cell tumor with special reference to VAB-6 therapy].
    Iwasaki M; Kazama T; Nakada T; Katayama T
    Hinyokika Kiyo; 1988 May; 34(5):883-8. PubMed ID: 2459940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
    Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
    Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemotherapy of testicular tumors].
    Cortes Funes H; Leiva Galvis O
    Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
    [No Abstract]   [Full Text] [Related]  

  • 31. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
    Stoter G; Sylvester R; Sleijfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M
    Cancer Res; 1987 May; 47(10):2714-8. PubMed ID: 2436756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
    Subramanian VS; Gilligan T; Klein EA
    Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular cancer: an oncological success story.
    Einhorn EH
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2630-2. PubMed ID: 10068265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
    Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
    J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.